Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
All News
Headline News
Press Releases
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Baidu Stock Rises To 2-Year High In Hong Kong As Investors Bet On AI Prowess — Retail Mood Flips To ‘Bullish’
Via Stocktwits
Topics Artificial Intelligence
Tickers BIDU KGRN VTI
Exposures Artificial Intelligence
Kratos Defense Stock Is Trending Amid $274,000 Executive Stock Sale
Via Benzinga
Tickers KTOS
Tesla Robotaxi Rival Waymo Reaches 96 Million Driverless Miles As Robotaxi Race Heats Up
Via Benzinga
Tickers GOOG GOOGL TSLA
Chuck Schumer Says Trump Wants A Government Shutdown: 'He Doesn't Want To Do Anything About The Crisis He's Created'
Via Benzinga
Topics Government
Exposures Political
Donald Trump Arrives In UK For Second State Visit As $42 Billion US Tech Investment Boosts AI And Quantum Projects
Via Benzinga
Topics Artificial Intelligence Government
Tickers GOOG GOOGL MSFT NVDA
Exposures Artificial Intelligence Political
StubHub Garners Bullish Retail Buzz Ahead Of NYSE Debut
Via Stocktwits
Niche Jewellery Brand Shringar House of Mangalsutra Makes Warm Market Debut; Lists at 14% Premium
Via Stocktwits
Amazon CEO Andy Jassy Vows To Make E-Commerce Giant Leaner And Meaner By Rooting Out ‘Anathema’ Of Bureaucracy
Via Stocktwits
Tickers AMZN SPY
Peter Schiff Again Asks Why Bitcoin Isn't Hitting New Highs Like Stocks, Gold, Miners ETF — Here Is What BTC Backers Are Saying
Via Benzinga
Topics ETFs
Tickers GDX
Gene Munster Calls Liquid Glass iOS 26 And iPhone 17 Hardware Refresh 'Good News' For Apple's Growth In FY 26
Via Benzinga
Tickers AAPL
5 Revealing Analyst Questions From Oxford Industries’s Q2 Earnings Call
Via StockStory
Topics Earnings World Trade
Tickers CB
Exposures Financial Tariff
Reliance ‘A Diversified Play’ Ahead Of Jio, Retail IPOs: SEBI Analyst Sees Bullish Breakout Above ₹1,525
Via Stocktwits
5 Insightful Analyst Questions From Chewy’s Q2 Earnings Call
Via StockStory
Topics Earnings
Tickers CHWY
Exposures Financial
Sensorion Reports 2025 Half-Year Results, Provides Corporate Update and Announces Availability of Half-Year Report
From Sensorion
Via Business Wire
MaaT Pharma Publishes Its Half Year 2025 Results and Provides a Business Update
From MaaT Pharma
Via Business Wire
H1 2025 Trading Update: EBITDA Up 15% YoY. Strong Results, Better Outlook
From GEVORKYAN, a.s.
Via GlobeNewswire
Ordos’ ‘warm city’ video contest attracts global participation
Via Binary News Network
Tickers TCEHY
MetaFusion Completes U.S. Compliance Registration and Launches Global Expansion Strategy
Via Binary News Network
SIG High Net Worth VIP Profit Program
Via Binary News Network
ADTRAN Holdings, Inc. Prices Upsized $175.0 Million Convertible Senior Notes Offering
From ADTRAN Holdings, Inc.
Via Business Wire
Tickers ADTN
Oruka Therapeutics Announces $180 Million Private Placement
From Oruka Therapeutics, Inc.
Via GlobeNewswire
Tickers ORKA
3 steps you can take now to help get your brand into AI overviews
Via Brandpoint
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Economy
Dermata Therapeutics Announces Presentation of Abstract at the European Academy of Dermatology and Venereology Congress 2025
Via ACCESS Newswire
Tickers DRMA DRMAW
Imagen Network (IMAGE) Expands Blockchain Interoperability by Adopting XRP Ledger Support
Via Newsfile
Topics Artificial Intelligence
Exposures Artificial Intelligence
Innate Pharma Reports First Half 2025 Business Update and Financial Results
From Innate Pharma SA
Via Business Wire
Tickers IPHA
Incyte Announces New 24-Week Phase 3 Data from the STOP-HS Clinical Trial Program of Povorcitinib in Hidradenitis Suppurativa at EADV 2025
From Incyte
Via Business Wire
Tickers INCY
Galderma’s Groundbreaking Real-World Study Reveals the Biological Toll of Modern Living and Urban Environments on Sensitive Skin
From Galderma SA
Via Business Wire
Informatica Named One of America’s Best Midsize Companies by TIME Magazine and Honored by The Financial Times as One of Europe’s Top Employers
From Informatica
Via Business Wire
Tickers INFA
Navigator Medicines Announces Positive Phase 1a Data from its Program of Potential Best-in-Class Bispecific Antibodies; NAV-240 Poised for Further Development in Inflammatory Disorders and Autoimmune Diseases
From Navigator Medicines INC
Via GlobeNewswire
Press Release: EADV: Sanofi’s brivekimig achieved positive results in hidradenitis suppurativa in phase 2a study
From Sanofi Winthrop Industrie
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.